Covidien has released its EverFlex+ self-expanding peripheral endovascular stent in Europe. The new version of the stent, third in the series, was designed to improve durability when flexed and elongated, and is available in sizes up to 200mm in length.
The new EverFlex+ system is designed to reduce the risk of fracture when elongated, improving clinical outcomes for patients. The next generation system offers the same customized technology as the current EverFlex system, retaining similar radial strength and flexibility, but adds even more durability. The EverFlex family of products is engineered to provide unmatched durability in a highly flexible platform, representing a significant advance in nitinol self-expanding stent technology.
Optimized architecture redistributes stress across the stent, reducing “hot spots” that contribute to fracture During bench testing of elongated stents, the 6 mm EverFlex+ stent ran through nine times more cycles
(average for all diameters was 5.5 more cycles) than EverFlex before showing signs of fracture
Spiral connection design enables uniform shape retention when EverFlex+ is placed in tortuous vessels
Bench-testing in 6 mm stents revealed no compromise in radial force with EverFlex+ when compared with EverFlex In other diameters tested, EverFlex+ radial force remained comparable to EverFlex (average was a 2%
EX.P.R.T. Deployment System holds stent securely in place to prevent premature deployment or
Tantalum GPS markers enhance visibility, enabling precise positioning